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Background: Influenza infection causes respiratory disease that can lead to death. The complex interplay between
virus-encoded and host-specific pathogenicity regulators – and the relative contributions of each toward viral
pathogenicity – is not well-understood.
Results: By analyzing a collection of lung samples from mice infected by A/Vietnam/1203/2004 (H5N1; VN1203), we
characterized a signature of transcripts and proteins associated with the kinetics of the host response. Using a new
geometrical representation method and two criteria, we show that inoculation concentrations and four specific
mutations in VN1203 mainly impact the magnitude and velocity of the host response kinetics, rather than specific
sets of up- and down- regulated genes. We observed analogous kinetic effects using lung samples from mice
infected with A/California/04/2009 (H1N1), and we show that these effects correlate with morbidity and viral titer.
Conclusions: We have demonstrated the importance of the kinetics of the host response to H5N1 pathogenesis and
its relationship with clinical disease severity and virus replication. These kinetic properties imply that time-matched
comparisons of ‘omics profiles to viral infections give limited views to differentiate host-responses. Moreover, these
results demonstrate that a fast activation of the host-response at the earliest time points post-infection is critical for
protective mechanisms against fast replicating viruses.
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ScalingBackground
Highly pathogenic H5N1 avian influenza (HPAI) viruses
cause rare but severe disease in humans, with a case fa-
tality rate approaching 60% among laboratory-confirmed
cases. Although direct human-to-human transmission of
these viruses does not occur, recent evidence suggests
that only a few molecular changes in the viral surface
hemagglutinin (HA) protein are sufficient to convert a
non-transmissible HPAI virus into one capable of drop-
let transmission in the ferret model [1-3]. These findings* Correspondence: honey@u.washington.edu
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reproduction in any medium, provided the orraise concern over the possibility of a HPAI virus pan-
demic, and underscore the critical need for a better un-
derstanding of the mechanisms that control HPAI virus
pathogenicity. Furthermore, the molecular dynamics
of the host response and the complex interplay be-
tween virus-encoded determinants, host regulatory fac-
tors, H5N1 pathogenesis and severe lung disease is not
well understood. Such information is essential for the de-
velopment of more effective intervention strategies aimed
at ameliorating human disease and loss of human life
resulting from HPAI virus infections.
To unravel this interplay, we performed a systematic
characterization of the global host response at the tran-
script and protein levels in lungs of mice infected by a
panel of viruses that vary in pathogenicity, using a rangeral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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tion of several corresponding phenotypic variables, includ-
ing mouse body weights, lung virus titers, viral messenger
RNA, and viral genomic RNA for each infected animal.
Our panel of viruses included the A/Vietnam/1203/2004
[H5N1] wild-type virus (VN1203-WT), the lower patho-
genicity A/California/04/2009 [H1N1] wild-type virus
(CA04-WT), two previously described VN1203 mutant
viruses – VN1203-HAavir [2] and VN1203-PB2-627E [4] –
and two newly generated VN1203 mutant viruses –
VN1203-NS1trunc and H5N1 VN1203-PB1F2del.
The H5N1 VN1203-WT virus is extremely virulent in
mice [5], and elicits a host response that contributes in
part to its pathogenicity [6]. The H5N1 VN1203-HAavir
mutant virus harbors an altered multi-basic cleavage
site – a virulence factor important for expanded tissue
range [7-9] – and exhibits restricted systemic viral spread
due to limited HA susceptibility to furin protease activity.
The H5N1 VN1203-PB2627E mutant possesses an amino
acid substitution (Lys-to-Glu) at position 627 in the PB2
polymerase subunit. This mutation is known to confer
increased polymerase activity in mammalian cells [10],
and also modulates anti-viral activity, apoptosis, and viral
clearance [11]. Our newly generated H5N1 VN1203-
NS1trunc mutant virus produces a 91 amino acid C-
terminal truncation in the effector domain of the
NS1 host response antagonist protein. The NS1 pro-
tein inhibits RIG-I activation [12] and cellular mRNA
processing [13], and also promotes PI3K activation [13].
The truncation results in the loss of the NS1 nuclear
localization signal, a PI3K-binding motif, and binding do-
mains that support interactions with the cellular nuclear
proteins CPSF and poly (A)-binding protein II (PABII) –
two factors that function in the 3’-end-processing of cel-
lular pre-mRNAs [14,15]. The newly generated H5N1
VN1203-PB1F2del mutant lacks expression of the PB1-
F2 protein, potentially impacting an array of functions.
PB1-F2 is a viral pathogenicity factor in mammals and
birds [16], and has been shown to modulate viral poly-
merase activity [17,18], enhance lung inflammation [19],
modulate innate immune responses [20,21], and demon-
strate pro-apoptotic activity [14]. Finally, the CA04-WT
virus, which is an H1N1 isolate from the 2009 pandemic
season, induces lower pathogenicity in mice relative to
VN1203 [5,22].
The extensive systematic analysis of transcriptomic
and proteomic pulmonary responses to wild-type and
mutant viruses we report here provides an unprece-
dented opportunity to assess the effect of specific virus
attenuating mutations on global host responses in vivo,
as well as the opportunity to directly examine the effects
of dosage on the elicited host response. Here, we sought
to specifically address how the kinetics of the host re-
sponses to the different viral infections differs, and howthis kinetics is related to the outcome of infection. To
address this, we used a systems biology approach to
analyze this dataset, and we developed a new geomet-
rical representation method and two criteria – the mag-
nitude and velocity coefficients – to visualize and
quantify the kinetics of the host response to the different
viral infections. Using this approach, we have established
that it is the magnitude and velocity of the early host
response, rather than engagement of specific biological
pathways per se, which mainly contributes to the ob-
served pathogenicity of influenza viruses. Importantly,
we show that the molecular kinetic of the host re-
sponse was associated with clinical disease severity and
virus replication.
Results
Assembly of phenotypic variables and lung transcriptomic
and proteomic profiles from mice infected with low and
high pathogenicity influenza viruses
We collected 230 transcriptomic and 198 proteomic pro-
files from the lungs of 20–week old C57BL/6 mice infected
with CA04-WT, VN1203-WT, VN1203-HAavir, VN1203-
PB2627E, VN1203-NS1trunc, or VN1203-PB1F2del. Mice
were infected with a range of inoculation dosages (from
102 to 106 Plaque Forming Unit – PFU) and lungs were
harvested at 1, 2, 4 and 7 days post-infection (dpi) to meas-
ure gene expression using oligonucleotide arrays and ob-
tain proteomic profiles by liquid chromatography–mass
spectrometry (LC-MS). Time-matched lung samples from
mock-infected mice were collected and a total number of
300 transcriptomic profiles and 266 proteomic profiles are
represented in our dataset.
Throughout this article, we use the following defini-
tions to describe the different conditions: (i) biological
condition refers to all samples infected by the same
virus, at the same inoculation dose, and from the same
dpi; (ii) dosage condition refers to samples infected by the
same virus and at the same inoculation dose; (iii) strain
condition refers to all samples infected by the same virus.
Based on these criteria, the dataset is divided into 51
transcriptomic biological conditions and 42 proteomic
biological conditions, representing 13 transcriptomic and
11 proteomic dosage conditions, and 6 strain conditions.
Additional file 1: Figure S1 provides a schematic repre-
sentation of the collected infected ‘omics profiles across
the time course.
The different viruses can be ranked based on their
pathogenicity as determined by Median Lethal Dose
(MLD) values in 6-week-old BALB/c mice (Figure 1A).
The VN1203-WT (MLD < 1 PFU) and the VN1203-
PB1F2del (MLD = 3.2 PFU) viruses were associated
with the highest level of pathogenicity. The CA04-WT
(MLD = 630,957 PFU; previously determined [22]) and the
VN1203-HAavir (MLD = 316,228 PFU) viruses were
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Figure 1 MLD and phenotypical variables collected for all viruses at the 104 PFU infection dosage. (A) Median lethal dose (MLD) values of
the different viruses in 6-week-old BALB/c mice. MLD values for VN1203 and mutants were performed in one experiment (3 mice per inoculation
dosage), and the previously calculated MLD for CA04 is included for comparison [22]. (B) Mice body weight measurements collected each day
from 1 to 7 days post-infection for the 104 PFU infection dosages. For each virus and time point, the mean and the standard deviation of the
mice body weight measurements are indicated by a vertical bar. (C), (D) and (E) Viral titer, viral messenger RNA, and viral genomic RNA
measurements collected at 1, 2, 4 and 7 days post-infection for the 104 PFU infection dosages. For each virus and time point the set of individual
measurements are indicated by filled dots and the mean amongst the individual samples is indicated by a horizontal bar. For the experiments
shown in panels B-E, four to five mice were used for all VN1203-WT and pathogenicity mutant infections, while 3–4 mice were used for the CA04
infections. The same animals were used to derive all the phenotypical data (i.e. weight loss, virus titer and virus mRNA/genomic RNA levels).
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VN1203-NS1trunc (MLD = 631 PFU) and the VN1203-
PB2627E (MLD = 6,310 PFU) viruses showed an inter-
mediate level of pathogenicity.
Morbidity associated with infection, determined by
mouse body weight loss (Figure 1B), viral replication quan-
tified by viral titration (Figure 1C), viral messenger RNA
(Figure 1D), and viral genomic RNA (Figure 1E) measured
by quantitative RT-PCR were used to characterize the
viruses in our study. These data were collected in the
same experiment in which mouse lung tissues were
collected for global transcriptome and proteome profil-
ing. Over the 7-day time course, VN1203-WT and all of
the mutant viruses – with the exception of VN1203-
PB2627E – exhibited similar, rapid weight loss culminat-
ing in a 20-30% reduction from initial body weights by
5–7 days post-infection (Figure 1B). In contrast, both
VN1203-PB2627E and CA04-WT displayed a more re-
duced rate of weight loss, which peaked at ~17% on day
7 post-infection. None of the mice survived to day 7 for
the VN1203-WT infection at 104 PFU. Virus titers were
roughly distributed from low to high according to virus
pathogenicity, with CA04-WT exhibiting the lowest
mean titer in all four time-points and VN1203-WT
exhibiting the highest (Figure 1C; see Additional file 2:
Figure S2 for statistical comparisons). The one exception
was titers observed in VN1203-HAavir infections, which
rivaled that of VN1203-WT in all time-points. Both viral
messenger RNA and genomic RNA production levels
exhibited early (day 1) segregation into two groups,
with VN1203-PB2627E and WT-CA04 displaying a
1–1.5 log10–fold reduction in expression compared to
all the other viruses (Figure 1D and E and Additional file 2:
Figure S2). Viral RNA expression levels remained partially
segregated on day 2, and by day 4, expression levels were
more similar for all viruses in the panel.
In brief, influenza viruses used in this study exhibited
a range of lethality, morbidity, and replication in mice.
Consistent with our expectations, the VN1203-WT virus
was the most virulent, with a very low MLD, the most
rapid weight loss, and the highest virus replication at
early dpi (day 1 and 2).
Gene magnitude changes significantly distinguish
the strain and biological conditions
Deletion of PB1-F2, K627E substitution in PB2, elimin-
ation of the HA multi-basic cleavage site, and truncation
of NS1 all decreased VN1203 virulence in mice, and
CA04-WT shows the lowest virulence in mice. We first
aimed to determine whether the attenuated phenotype
for each virus was the result of a different host response.
For each biological condition, differentially expressed
transcripts (DET) and proteins (DEP) compared to the
mock-infected samples were identified and the overlapbetween the lists of DET or DEP of each virus were
compared. Figure 2A and B provide visual representa-
tions of the intersections between the lists of DET
and DEP for the strain conditions using proportional
Euler-diagrams [23]. There were large degrees of over-
lap (defined here as the percentage of DET or DEP
also found in another condition) between the strain con-
ditions, between 69.41% - 99.62% and 85.94% - 96.98%,
DET and DEP, respectively. The VN1203-PB1F2del strain
condition had the smallest degree of overlap at the
transcriptomic (69.41%) level, and a relatively small de-
gree at the proteomic (87.95%) levels. Notably, at 7 dpi,
only one transcriptomic profile was available for the
VN1203-PB1F2del strain condition inoculated at the 104
PFU concentration. Hence, with only one sample avail-
able, the statistical identification of DET lead to the iden-
tification of a fraction of false-positive, explaining this
lowest degree of overlap observed for this strain condi-
tion at the transcriptomic level. The VN1203-WT strain
condition also showed a relatively small degree of overlap
at the transcriptomic (85.55%) level; and the VN1203-
NS1trunc strain condition showed the smallest degree
of overlap at the proteomic (85.94%) level compared
to the other strain conditions. It should be noted that
the strain conditions with the lowest degrees of over-
lap corresponded to the same strain conditions that
triggered the largest amount of DET and DEP. Similar
large amounts of overlap have been identified between
the dosage conditions, with degrees of overlap ranging
from 68% to 98.81% for the transcriptome and from
89.87% to 99.89% for the proteome. Despite differences
in clinical manifestation of the disease, these results sug-
gest that the specific mutations in VN1203 examined
herein resulted in the induction of similar groups of tran-
scripts and proteins compared to VN1203-WT, implying
that magnitude and/or the kinetics of dysregulation of
these overlapping genes might differentiate the viruses.
Figure 2C is a heatmap of the transcript expression
values, ratioed to the mock-infected samples, of each
infected sample of our dataset. This heatmap has been re-
stricted to the lists of transcripts specific to each strain
condition (i.e. transcripts found as differentially expressed
within one viral strain but not in the others). We cannot
distinguish any particular patterns or sets of transcript spe-
cific to any viral strain based on these transcript expression
values. The transcript or protein subsets specific to each
viral strain are the consequences of small variations in the
host response, detected by the statistical procedures, that
have no specific biological meaning.
Functional enrichment analysis of the biological condi-
tions also indicated a large degree of overlap in the host
response – at least qualitatively – irrespective of the virus
used to infect the mice. For instance, Acute Phase Re-
sponse Signaling, Antigen Presentation Pathway, LXR/RXR
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Figure 2 (See legend on next page.)
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Figure 2 Intersections between the lists of DET and DEP for the strain conditions. (A) and (B) Proportional Euler-diagrams showing the
intersections between the lists of differentially expressed transcripts and proteins identified for the strain conditions. Proportional Euler-diagrams
visually represent the cardinalities of sets and intersection sets of differentially expressed transcripts or proteins by area-proportional circle
graphics. Each list of DE transcripts or proteins is then represented by a circle with a diameter proportional to the cardinality of the list and the
overlaps between the circles are proportional to the cardinality of the intersections between the lists. For each strain condition the number of
transcripts or proteins found as DE in the host response is indicated as well as the degree of overlap — quantified as the percentage of
transcripts or proteins also found as differentially expressed in another condition. (C) Heatmap of the transcriptomic expression values, ratioed to
mock-infected samples, for each infected sample. The heatmaps have been restricted to the lists of transcripts found as specific for each viral
strain and the different subsets of transcripts specific are indicated. For each set of specific transcripts, hierarchical clustering have been
performed and represented using dendrograms. Biological samples have been ordered by strain conditions, sorted by inoculation concentrations
and then by increasing days post-infection. (D) Heatmaps showing the statistical over-representation of the canonical pathways based on the lists
of transcripts found as differentially expressed (compared to the mock-infected conditions) for each of the 51 biological conditions. This heatmap
has been restricted to only display the top canonical pathways over-represented across all the dataset.
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versally enriched (Figure 2D). Differences between the bio-
logical conditions were mainly explained by different
degrees of enrichment scores, smaller for the early time-
points post-infection and larger for the late time-points
post-infection. Similarly, within each viral strain, the
enrichment scores were smaller for the lower infection
concentrations and larger for the higher infection concen-
trations. Overall, the qualitative similarity in the host
transcriptomic and proteomic response to various influ-
enza viruses suggested that the different viruses stimulate
activation of common host response signaling mechanisms
with different degrees of magnitude.
Altogether, these results demonstrate that it is mainly
the magnitude of expression changes within the same
transcripts or proteins, rather than the induction of dif-
ferent gene sets, that differentiate the host response to
CA04-WT, VN1203-WT, and H5N1 VN1203 mutants.
Thus, isogenic viruses and different inoculation dosages
likely trigger the same differentially regulated genes,
but with different degrees of magnitude at both the
transcriptomic and proteomic levels. This analysis was
performed on the transcriptomic and proteomic levels
independently, and in parallel. Though we noted this
magnitude effect was stronger in the proteomic dataset
compared to the transcriptomic dataset, we found the
same conclusions in each separate analysis.
The kinetics of the host response to VN1203-WT is captured
by 3 main eigentranscripts and 3 main eigenproteins
To better characterize the host responses, and to be able to
quantify their kinetics, we used a Singular Value Decom-
position analysis to capture and cluster transcripts and pro-
teins associated with the system’s dynamics, as described in
[24]. Transcripts and proteins previously identified as dif-
ferentially expressed in at least one biological condition
that correlated with the eigentranscripts or eigenproteins
(right-singular vectors of the singular value decomposition)
were identified using the Pearson’s coefficient, with
eigentranscripts or eigenproteins representing significantpatterns of expression profiles, associated with the kinetics
of the system. Transcripts and proteins that did not correl-
ate with any eigentranscript or eigenprotein, respectively,
were not considered as significantly associated in the dy-
namics of the host response (Pearson’s coefficient cutoff =
0.65). This approach was used to examine the host
response to VN1203-WT, independently of the inoculation
dosage, that was then subsequently used as a reference to
compare the VN1203 mutants and CA04-WT. Mock
infected biological conditions were not used in the infer-
ence of eigentranscripts and eigenproteins, and biological
conditions at 1 dpi and 2 dpi were not used in the infer-
ence of the eigenproteins because of the relatively low
levels of proteins detected as differentially expressed at
these time-points.
We found a total of 5,660 transcripts that correlated with
3 main eigentranscripts (eigentranscript #1 contained
2,706 transcripts, eigentranscript #2 contained 2,826
transcripts, and eigentranscript #3 contained 128 tran-
scripts). There were a total of 162 proteins that correlated
with 3 main eigenproteins (eigenprotein #1 contained
59 proteins, eigenprotein #2 contained 86 proteins,
and eigenprotein #3 contained 17 proteins). Additional
file 3: Table S1 and Additional file 4: Table S2 provide
the lists of transcripts and proteins associated with each
eigentranscript and eigenprotein, respectively. The pat-
terns of the eigentranscripts and eigenproteins identified
in the VN1203-WT host response are represented in
Figure 3A and B. Eigentranscript #2 was increasing over
time, whereas eigentranscript #1 was decreasing over
time. Eigentranscript #3 showed a distinct pattern with a
transient decrease at 2 and 4 dpi, followed by an increase
at 7 dpi. Eigenprotein #1 was increased in abundance
over time. In brief, the dynamics of the transcriptomic
and proteomic host response were captured by 3 sets of
co-expressed transcripts and 3 sets of co-expressed pro-
teins with different patterns of variations.
For each set of transcripts and proteins, we identi-
fied over-represented biological functions, canonical
pathways, and upstream regulators (Tables 1 and 2).
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Figure 3 Eigengenes in the kinetics of the VN1203-WT response, and MDS representations of the infected samples. (A) and (B) Profiles
of the eigentranscripts and eigenproteins identified in dynamic of the host response to H5N1 VN1203 wild-type. Number of transcripts and
proteins correlating with each eigentranscript and eigenprotein are indicated. All the individual shape represent the transcriptomic or proteomic
profile of a mice lung infected by the VN1203 wild-type virus. Biological samples have been sorted by inoculation concentrations and then by
increasing days post-infection. (C) and (D) Multidimensional Scaling representations of the transcriptomic and proteomic profiles of the H5N1
VN1203 wild-type infected samples. Each dot in the representations is the transcriptomic or proteomic profile of a biological sample plotted in
the intensity space of expression signals. Pairwise distances between the dots are proportional to the transcriptomic or proteomic distances
between the samples. Transcriptomic and proteomic distances have been calculated based on the signature of 5,660 transcripts and 162 proteins
that significantly correlate with one eigentranscript or eigenprotein. Dots are colored in order to indicate the dosage conditions, and biological
conditions are indicated by the convex hull of the set of biological replicates and labeled to indicate the time point post-infection. The Kruskal
Stress shown in each representation quantifies the quality of the geometrical representation as a fraction of the information lost during the
dimensionality reduction procedure. Schematic projections of the Magnitude and Velocity Coefficients are illustrated at 104 PFU in the
transcriptomic MDS representation. The Magnitude Coefficient MC at 2 dpi – quantifying the transcriptomic distance between mocks and 2 dpi
samples – is illustrated by a dashed red line, and the Velocity Coefficient (VC) at 4 dpi – measuring the velocity between 4 and 2 dpi samples
divided by time – is illustrated by an arrow dashed red line.
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Table 1 Functional enrichment of the eigentranscript identified in the host response kinetics to VN1203
Eigentranscript
(No. of molecules)
Bio functions category
(functions annotation p-value range)
Canonical pathway (p-value) Upstream regulator
(p-value of overlap)
eigentranscript #1 (2706) Embryonic development (5.55E-11–5.24E-03) Axonal guidance signaling (8.71E-07) NKX2-1 (5.35E-13)
Organ development (5.55E-11–5.24E-03) Basal cell carcinoma signaling (1.82E-05) PPP3R1 (2.10E-11)
Organismal development (5.55E-11–5.24E-03) Glutathione-mediated detoxification (6.61E-05) DMD (1.36E-05)
Tissue development (5.55E-11–5.24E-03) Xenobiotic metabolism signaling (2.19E-04) BMP6 (6.45E-05)
Respiratory system development and
function (1.19E-10–2.38E-03)
Tryptophan degradation (4.68E-04) GLI1 (1.38E-04)
eigentranscript #2 (2826) Cellular function and maintenance
(3.38E-55–2.01E-09)
Death receptor signaling (5.01E-09) LPS* (9.74E-111)
Cellular function and maintenance
(3.38E-55–2.01E-09)
Apoptosis signaling (7.94E-09) IFNG (2.42E-87)
Hematological system development and
function (1.34E-51–3.31E-09)
Role of pattern recognition receptors in
recognition of bacteria and viruses (1.78E-08)
TNF (8.84E-65)
Tissue morphology (5.34E-51–2.48E-10) Induction of apoptosis by HIV1 (4.07E-08) IL1B (1.15E-56)
Cellular growth and proliferation
(5.55E-11–5.24E-03)
Protein ubiquitination pathway (4.17E-08) TP53 (6.72E-55)
eigentranscript #3 (128) Cell cycle (1.67E-11–1.60E-02) Pyrimidine deoxyribonucleotides de novo
biosynthesis I (5.13E-05)
E2F4 (5.42E-12)
Cell cycle (1.67E-11–1.60E-02) T Cell receptor signaling (1.70E-04) FOXM1 (1.84E-11)
Cellular development (5.83E-10–1.60E-02) iCOS-iCOSL signaling in T helper cells (2.69E-04) CDK4 (1.44E-10)
Hematological system development and
function (5.83E-10–1.60E-02)
Mitotic roles of polo-like kinase (4.47E-04) CDKN1A (1.09E-09)
Hematopoiesis (5.83E-10–1.60E-02) Regulation of IL-2 expression in activated and
anergic T lymphocytes (8.51E-04)
CCND1 (1.66E-09)
For each eigentranscript identified in the kinetics of the host response to H5N1 VN1203 wild-type, the number of correlating transcripts is indicated. For each set
of transcript the top 5 associated over-represented biological functions, canonical pathways, and upstream regulators are indicated. Ingenuity pathway analysis
was used to determine the top 5 bio function categories, canonical pathways, and upstream regulators. The functions annotation p-value range represents the
range of p-values for the functions annotations associated with each bio function category. The p-value of overlap associated for each upstream regulator
indicates the significance of the overlap between the genes targeted by the upstream regulator in the IPKB database and the experimental dataset. *Upstream
regulators with an apteryx signify a chemical reagent or chemical drug.
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associated with Death Receptor Signaling, Role of Pat-
tern Recognition Receptors in Recognition of Bacteria and
Viruses, and Apoptosis Signaling, as well as the Protein
Ubiquitination Pathway, which has previously been ob-
served in mouse lung responses following pandemic 1918
influenza virus infection [25]. There was representation
of transcripts encoding immuno proteasome compo-
nents (e.g., PSMB9 and PSMB10), ubiquitin-protein
conjugates (e.g., USP18 and USP3), and heat shock
proteins (e.g., HSPA5 and HSPB7) accompanying the
Protein Ubiquitination Pathway. Eigentranscript #1 profile
was comprised of transcripts predominantly associated
with metabolic cellular processes including Glutathione-
mediated Detoxification (e.g., GSTK1 and GSTA3) and
Xenobiotic Metabolism Signaling (e.g., AHR and CAT). Re-
spiratory System Development and Function was an
enriched biological function for eigentranscript #1 that in-
cluded RARG and RARB transcripts, two ligand-dependent
nuclear receptors that modulate an array of cellular re-
sponses related to cellular growth. Eigentranscript #3
profile was enriched for transcripts associated with T cellresponses, CD3G, ZAP70, and ICOS, related to T Cell
Receptor Signaling, iCOS-iCOSL Signaling in T Helper
Cells, and Regulation of IL-2 Expression in Activated
and Anergic T Lymphocytes. Activated CD8 T cells in
the lungs of mice infected with H5N1 virus are impaired
in their ability to control viral replication linked to high
pathogenicity [26].
Eigenprotein #2 profile had strong representation
of proteins associated with Acute Phase Response
Signaling (e.g., SAA2 and SERPINA1), LXR/RXR Acti-
vation (e.g., APOA1 and APOA2), Complement System
(e.g., CFB and C4B) and Coagulation System (e.g., F2
and FGG), cellular responses that are critical to host
antiviral defenses. Examination of proteins associated
with eigenprotein #1 profile showed enrichment of pro-
teins related to modification of reactive oxygen species.
For example, there was enrichment of PRDX1, PTPLAD1,
and ERP29, suggesting heightened oxidative stress re-
sponses in the lungs of VN1203-infected mice. H5N1
infection causes acute lung injury and mice inoculated
with inactivated H5N1 virus have compromised lung
function, including altered lung elastance and increased
Table 2 Functional enrichment of the eigenproteins identified in the host response kinetics to VN1203
Eigenprotein
(No. of molecules)
Bio functions category
(functions annotation p-value range)
Canonical pathway (p-value) Upstream regulator
(p-value of overlap)
eigenprotein #1 (59) Free radical scavenging (8.24E-07–2.56E-02) NRF2-mediated oxidative stress response (2.40E-05) D3T* (2.77E-06)
Drug metabolism (3.50E-05–2.87E-02) Glutathione-mediated detoxification (2.69E-04) MAPT (6.72E-06)
Auditory disease (6.12E-05–6.12E-05) G Beta gamma signaling (2.82E-04) TP53 (8.41E-06)
Developmental disorder (1.52E-04–2.56E-02) Ceramide signaling (2.45E-03) NFE2L2 (1.40E-05)
Hereditary disorder (1.52E-04–6.45E-03) EIF2 signalin (3.02E-03) PSEN1 (1.16E-04)
eigenprotein #2 (86) Neurological disease (3.89E-08–8.48E-03) Acute phase response signaling (1.26E-25) Nitrofurantoin* (3.03E-12)
Cell-to-cell signaling and interaction
(8.90E-08–1.08E-02)
LXR/RXR Activation (1.58E-13) Captopril* (1.79E-08)
Tissue development (8.90E-08–1.08E-02) Clathrin-mediated endocytosis signaling (9.77E-08) IL6 (1.83E-07)
Metabolic disease (2.66E-07–1.02E-02) Complement system (3.02E-07) Gentamicin* (5.04E-07)
Lipid metabolism (5.24E-07–1.17E-02) Coagulation system (3.55E-07) T3
* (8.12E-07)
eigenprotein #3 (17) Cell death and survival (1.82E-05–4.83E-02) Breast cancer regulation by Stathmin1 (1.70E-05) PLG (2.14E-04)
Hematological system Development and
function (9.90E-05–4.48E-02)
Cardiac β-adrenergic signaling (1.91E-04) APP (1.19E-03)
Organismal injury and abnormalities
(1.63E-04–4.83E-02)
AMPK signaling (2.24E-04) PSEN1 (2.06E-03)
Tissue morphology (8.38E-04–4.19E-02) CREB signaling in neurons (4.07E-04) MAP2 (2.12E-03)
Cancer (8.38E-04–4.99E-02) Role of NFAT in cardiac hypertrophy (4.57E-07) GNG7 (2.12E-03)
For each eigenprotein identified in the kinetics of the host response to H5N1 VN1203 wild-type, the number of correlating transcripts and proteins are indicated.
For each set of proteins the top 5 associated over-represented biological functions, canonical pathways, and upstream regulators are indicated. Ingenuity pathway
analysis was used to determine the top 5 bio function categories, canonical pathways, and upstream regulators. The functions annotation p-value range
represents the range of p-values for the functions annotations associated with each bio function category. The p-value of overlap associated for each upstream
regulator indicates the significance of the overlap between the genes targeted by the upstream regulator in the IPKB database and the experimental dataset.
*Upstream regulators with an apteryx signify a chemical reagent or chemical drug.
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[27]. Represented within eigenprotein #3 profile, were
APOH and PLG proteins involved in opsonization of
cells, as well as the NADH dehydrogenase components
NDUFA11 and NDUFA13.
In conclusion, the three sets of co-expressed transcripts
identified in response to VN1203-WT were associated
with immune and apoptosis signaling pathways that in-
creased over time, metabolic cellular processes that were
largely decreasing, and T cell signaling pathways that
exhibited a biphasic pattern. The three sets of proteins
capturing the host response dynamics were related to
host antiviral defenses, reactive oxygen species observed
to increase as infection progressed, and opsonization.
Notably, upstream regulators highly enriched in each of
the transcript or protein sets were identified (p-value
as low as 10-111 for LPS regulating eigentranscript #2),
which confirmed that this method captures groups of
co-regulated transcripts/proteins. Importantly, there
was an overlap of 29 signaling pathways that were
found in both transcript and protein sets, including
Role of NFAT in Regulation of the Immune Response,
Apoptosis Signaling and Coagulation System, suggesting
complementary sensitivity between the transcriptomic and
proteomic profiles.Different doses of VN1203 WT impact the magnitude
and velocity of the pulmonary response to infection
To determine the effects of increasing dosage on the
kinetics of the host response to VN1203-WT, we
used Multidimensional Scaling (MDS) [28,29] as a
visualization method and introduced two new criteria
quantifying magnitude and velocity changes in the signa-
ture (Figure 3C and D). Each dot in the MDS representa-
tions is the transcriptomic or proteomic profile of a
biological sample, and pairwise distances between dots
are proportional to the transcriptomic or proteomic dis-
tances (Euclidean distances) between the samples. The
MDS representation, calculated using the sets of tran-
scripts and proteins associated with the VN1203-WT
kinetics, highlighted interesting differences between the
dosage conditions. While all samples from different dos-
ages were close to the mocks at 1 dpi, the late time-
points followed a similar curved trajectory. Different
magnitudes, defined as the distance of one biological
condition to the mock-infected condition, and velocities,
defined as the speed of the host response moving from
one time point to the next time point, were observed for
the three dosage conditions for both the transcriptomic
and proteomic levels. For example, infection with the
highest dose of VN1203-WT virus (104 PFU) induced a
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infection with the lowest dose (102 PFU) observed 3 days
later at 7 dpi (Figure 3C). Compared to the transcriptomic
profiles, the MDS representation of the proteomic profiles
showed more noise in the data (Figure 3D). For instance,
we observed that the variations within the groups were as
high as the variations between groups. The proteomic sam-
ples collected at 1 and 2 days post-infection samples were
closely clustered with the mocks. Although we were unable
to differentiate these samples, we observed a similar effect
of dose on the trajectories at 4 and 7 dpi, with the highest
dose reaching the end of the trajectory more quickly com-
pared to the lower doses. As such, the biological interpreta-
tions derived from the proteomic analysis have to be taken
into careful considerations.
In order to quantify these magnitude and velocity ef-
fects in the kinetics of the host response, we defined two
criteria, the Magnitude Coefficient (MC) and the Velocity
Coefficient (VC). The MC quantifies the magnitude ef-
fect as the transcriptomic distance from one biological
condition to the matched mock-infected condition. The
VC quantifies the velocity effect as the speed of the
transcriptomic host response moving from one time
point to the next in the succession of infection. Both theA
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these transcripts/proteins and an increased velocity, es-
pecially between 1 and 2 dpi.
Mutations in VN1203 impact the magnitude and velocity
of the host response
Having characterized VN1203-WT dynamics, we were
now able to determine how each specific VN1203 mu-
tant altered the kinetics of the host responses. In par-
ticular, our aim was to better quantify the magnitude
differences between WT and mutants that were intro-
duced with Figure 2. We next developed a new geomet-
rical representation method in order to compare the
kinetics of the host response to the various VN1203
mutants relative to the host response to VN1203-WT
at the transcriptomic level. Using the MDS representa-
tion presented in Figure 3C as a reference, we projected
the transcriptomic profiles of samples infected by the
four VN1203 mutant viruses individually at 104 PFU
(Figure 5A-D) and, in the case of VN1203-NS1trunc
and VN1203-PB1F2del, at 103 and 104 PFU dosages
(Figure 5C and D). While traditional MDS methods
project a set of high dimensional objects into a lower
dimensional space for visualization purposes, the MDS
method that we developed allows for projection of add-
itional objects over a predefined MDS representation
(see Methods section). Thus, the resulting representa-
tion allows us to visualize the similarities and differ-
ences between the WT and mutant samples, and MC
and VC allow us to quantify the kinetic changes in the
host response related to magnitude and velocity, as pre-
viously described for VN1203-WT. The reference repre-
sentation is named a MDS Reference Map and the
resulting projections are named MDS Projections. Quan-
tification of magnitude and velocity revealed different
information about each mutant.
For VN1203-PB2627E, both the MDS projection
(Figure 5A) and the MC and VC profiles (Figure 4) for the
104 dosage were similar to that observed for VN1203-WT
at the 102 dosage. Therefore, the main effect of the PB2-
627E mutation on the host-response was to decrease it to a
level similar to that induced by 100 times less VN1203-
WT. This is consistent with the reduced replication we
observed for VN1203-PB2627E in the current study
(Figure 1B) and with a previous study showing that the
main effect of the PB2-627E mutation in the VN1203 back-
ground was to reduce virus replication in the lung [5].
The main effect of VN1203-HAavir was also found to
be an attenuated host response, with the VN1203-
HAavir 104 dosage exhibiting an MDS projection and
VC/MC profiles similar to that observed for VN1203
WT at the 103 dosage (Figures 4, and 5B). The only dif-
ference was that VC and MC at 4 dpi were slightly lower
than the VN1203-WT, while no difference in weight lossor viral replication was observed between the two vi-
ruses at that dpi.
Strikingly, whereas VN1203-PB1F2del VC and MC
profiles at 103 PFU were intermediate between VN1203-
WT 102 and 103, at the highest dose (104 PFU), both the
peak of VC at 2 dpi and the peak of MC at 7 dpi were
higher than VN1203-WT at the same dose (Figures 4
and 5C). It should be noted that both body weight loss
and virus replication were similar at this dose between
the VN1203-WT and this mutant (Figure 1). Moreover,
during the course of infection, four out of the five mice
died between 4 and 7 dpi, indicating a high virulence of
this mutant at 104 PFU.
Finally, the MC and VC profiles associated with VN1203-
NS1trunc mutation largely changed at early dpi (1 and
2 dpi). At 1 dpi, these 2 coefficients were higher in the
mutant than in the matched dose of the WT, but lower
at 2 dpi (Figures 4, and 5D). This was related to the en-
hanced, early expression (i.e. at 1 dpi, relative to 2 dpi for
all other viruses) of transcripts directly involved in the
innate immune response and inflammation (Additional
file 6: Figure S3), which was also reported previously
[31]. It was interesting to find that this behavior was very
similar to the CA04 at the highest dose (106 PFU).
CA04-WT was used as a much lower pathogenicity com-
parator which confirmed that the main effect of increasing
infection dose was to increase the magnitude of the host-
response (Additional file 7: Figure S4, and Figure 4).
To summarize, each mutant of VN1203 dysregulated
the kinetic signature of 5,660 transcripts with a specific
dynamic in terms of both magnitude of changes (MC),
and speed at which they occurred (VC). While VN1203-
PB2E627 and HAavir induced changes similar to those
induced by 100 or 10 times lower doses of VN1203-WT
respectively, VN1203-PB1F2del had a bimodal response
with attenuation at 103 PFU, but an increase in both
magnitude and velocity at 104 PFU. Finally, VN1203-
NS1trunc induced changes in the 5,660 transcripts with
a kinetics and magnitude more similar to CA04-WT 106
PFU than VN1203-WT.
Magnitude and velocity of the host responses are
associated with weight loss and viral titer
To determine whether the VC and MC were related to
disease outcome and viral pathogenicity, we performed a
correlation analysis between these coefficients and the
phenotypic variables. All biological conditions were consid-
ered together in these analyses to assess the correlations
with a large significance. For each biological condition, we
determined the mean body weight of the animals, viral
titer, viral messenger RNA and viral genomic RNA mea-
surements in the lung, and calculated the difference be-
tween the means of any two consecutive time-points for
viral titer (Δ mean viral titer), viral RNA (Δ mean viral
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Figure 5 MDS Projections of the VN1203 mutants infected transcriptomic profiles over the VN1203-WT Reference Map.
(A) Multidimensional Scaling Projection (MDS Projection) of the transcriptomic profiles of the VN1203-PB2627E dosage condition over the VN1203
wild-type Multidimensional Scaling Reference Map (MDS Ref Map). (B) MDS Projection of the transcriptomic profiles of the VN1203-HAavir dosage
condition over the VN1203 wild-type MDS Ref Map. (C) MDS Projection of the transcriptomic profiles of the VN1203-PB1F2del dosage conditions
over the VN1203 wild-type MDS Ref Map. (D) MDS Projection of the transcriptomic profiles of the VN1203-NS1trunc dosage conditions over the
VN1203 wild-type MDS Ref Map. Each dot is the transcriptomic profile of a biological sample plotted in the intensity space of gene expression.
Pairwise distances between the dots are proportional to the transcriptomic distances between the samples. MDS Projections allow to project
additional ‘omics profiles over a predefined MDS representation (MDS Ref Map). Transcriptomic distances have been calculated based on the
signature of 5,660 transcripts that significantly correlate with one eigentranscript. Dots are colored in order to indicate the dosage conditions, and
biological conditions are indicated by the convex hull (i.e. the smallest convex set containing the points [30]) of the set of biological replicates and
labeled to indicate the time point post-infection. Samples and biological conditions of the H5N1 VN1203 wild-type 104 PFU infection dosage are
indicated by gray dots and gray convex hulls. Hence the grey spots that are connected represent the -omics profiles of mice lung infected by the
VN1203 wild-type virus at 104 PFU, while the ones not connected represent the -omics profiles for the other infection concentrations. The Kruskal
Stress shown in each representation quantifies the quality of the geometrical representation as a fraction of the information lost during the
dimensionality reduction procedure.
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http://www.biomedcentral.com/1752-0509/7/69mRNA), and viral genomic RNA (Δ mean viral gRNA). For
each transcriptomic biological condition the associated
MC, VC, mean body weight, Δ mean viral titer, Δ mean
viral mRNA, and Δ mean viral gRNA values are shown in
Additional file 5: Table S3. A significant association was
found between MC and mean body weight (Spearman’s
rho = −0.7984), suggesting that the magnitude of host
response is significantly associated with morbidity
(Figure 6A). The VC was not significantly associated with
any criteria when considering phenotypic variables within
a given time-point; however, the VC was significantly asso-
ciated with Δ mean viral titer (Spearman’s rho= 0.8459,
Figure 6B), Δ mean viral mRNA (rho =0.8544), and Δ
mean viral gRNA (rho =0.8426) at the previous time-point.
This suggests that the velocity of the host response can be
predicted by changes in viral replication at the preceding
time-point.
In conclusion, the magnitude of changes in the host
response of the 5,660 transcripts was correlated with
morbidity at similar time-points, while the velocity of
these changes between two time-points was associated
with extent of changes in viral replication at previous
time-points.
Discussion
Highly pathogenic avian influenza H5N1 virus is known
to induce aberrant host responses leading to severe im-
munopathology in the lung. In particular, the potent
pro-inflammatory response, commonly referred to as
‘cytokine storm’, is the suspected cause of acute lung in-
jury [32]. Genomic evidence from animal model systems
shows HPAI H5N1 viruses strongly enhance cytokine andBA
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indicate the viral strain according to the nomenclature of Figure 1. For eac
well as the associated p-value.chemokine transcriptional responses compared to seasonal
influenza viruses (reviewed in [33]) and 2009 pandemic
H1N1 influenza viruses [34]. Here, we utilized a mouse
model to study the system dynamics of H5N1 infection,
comparing and contrasting the effects of increasing dosage
and different previously described and newly generated
viral mutants with varying degrees of pathogenicity toward
the kinetics of pulmonary responses. Using a systems ap-
proach, we present a temporal analysis of transcriptomic
and proteomic profiles measured from mouse lung sam-
ples collected during the acute phase of infection in order
to better understand both dose-dependent and temporal
mechanisms of host responses to influenza infection.
We report that the wild-type and mutant viruses differ-
entially regulate a common set of transcripts and pro-
teins, demonstrating a large degree of overlap in the host
response among the different strain and dosage condi-
tions. Regardless of the virus genetic change, we show
that the host response is mainly impacted by the magni-
tude of gene expression and the speed at which these
changes occur for this core set of transcripts, as opposed
to transcriptomic differences explained by each specific
mutation. We identified three main eigentranscripts as-
sociated with host immune mechanisms, including meta-
bolic cellular processes and T cell signaling pathways,
and three main eigenproteins associated with host anti-
viral defenses. Through a new geometric representation
method and two criteria (the magnitude and velocity co-
efficients), we were able to visualize and quantify the
magnitude and velocity kinetic effects of the host re-
sponse to wild-type and mutant H5N1 VN1203 viruses,
which were influenced by both the infection dosage and200 400 600 800 1000
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Intriguingly, two newly generated H5N1 VN1203 mutant
viruses, VN1203-PB1F2del and VN1203-NS1trunc, had
the most distinct profiles, with apparent displacement rela-
tive to all other viruses at 2 dpi and 1 dpi, respectively. The
divergent kinetic effects occurred mostly at early time-
points (between days 1 and 2 post-infection), and we
observed analogous kinetic effects with different doses of
low pathogenicity 2009 pandemic H1N1 influenza virus
(CA04-WT). Importantly, we demonstrate that the magni-
tude and velocity kinetic effects were associated with clin-
ical disease severity and virus replication. Specifically,
mouse weight loss correlated with the magnitude of the
host response, and infectious viral particle production at a
given time point correlated with the velocity of the host re-
sponse at the next time-point.
Compared to the differentially expressed transcripts,
changes in protein abundance were less apparent, due in
part to inherent noise in the data that makes computa-
tional analyses of proteomic measurements particularly
challenging [35,36]. However, we have been able to iden-
tify the same overall kinetic pattern, as observed with
the transcriptomic data. Due to this variability, we have
not used the proteomic data to quantify the magnitude
and velocity effects and the biological interpretations we
have drawn from the proteomic analysis have been done
with careful consideration.
Previous work by Chang and coworkers, using a com-
pendium of about 200 publicly available transcriptomic
profiles of mouse lungs, showed differences in pathogen-
icity among respiratory viruses were explained in part by
the changes in magnitude of gene expression [37]. How-
ever, due to constraints of the meta-analysis, time was
not taken into consideration. Moreover, the different
microarray platforms and mouse genetic backgrounds
used in the different datasets introduced noise into the
analysis. Here, we have expanded upon the findings by
Chang et al. through a kinetic analysis that incorporates
the dimension of time, uses a single mouse genetic back-
ground and isogenic respiratory viruses that differ based
on mutations to known pathogenicity determinants.
Transcriptomic and proteomic samples were collected
in a systematic manner to generate a comprehensive
dataset that provides a powerful resource for modeling
pathogen-host interactions. The large sample number al-
lows to infer co-expression and co-regulation networks
for identification of unknown associations and dynamic
interactions between biological components. Moreover,
the extensive collection of sampled time-points allows to
model causality of the biological system for discovery of
novel biological events. In addition, a large panel of ma-
chine learning and data mining algorithms can be used,
trained and tested based on this assembled dataset. While
our study focuses on acute responses to H5N1 virus,other transcriptomic datasets, such as the one reported
by Pommerenke and coworkers, encompass acute and
adaptive host responses to influenza virus [38]. It will be
important to consider changes during adaptive host re-
sponses to fully appreciate the impact of magnitude and
velocity kinetic effects on the outcome of viral infection.
Several genomic studies have examined host responses
to H5N1 virus in mice for a deeper understanding of
molecular events impacting viral pathogenesis and dis-
semination. Cillóniz and coworkers demonstrated robust
transcriptional changes of inflammatory response genes,
including upregulation of inflammasome genes (e.g.,
CASP1, IL1B, and NLRP3), in response to H5N1 VN1203
compared to 1918 pandemic influenza virus at day 1 post-
infection [6]. Investigation of the host response to viruses
possessing specific mutations has also been investigated.
For example, Fornek et al. showed that the H5N1 influenza
A/Hong Kong/486/97 virus containing amino acid substi-
tution E627K in PB2 upregulated TCR complex genes (e.g.,
CD3D and CD3G) in the lungs of infected mice at day 2
post-infection [11]. It must be noted that the PB2 mutation
is not the only difference between these two viruses. Our
kinetic analysis further supports the likelihood of impaired
T cell responses to H5N1 infection. In a separate study,
a recombinant virus expressing H5N1 PB1-F2 N66S
compared to the wild-type recombinant virus showed dif-
ferences in the timing of interferon-stimulated gene ex-
pression in mouse lung [20]. Proteomic analysis of primary
human monocyte-derived macrophages infected with
H5N1 virus have also been investigated and changes in
protein abundance of components associated with pro-
tein synthesis machinery have been observed as early as
1 hour post-infection [39].
Importantly, these kinetic properties of the host response
may not be fully captured by traditional statistical methods
that largely depend on different assumptions and applied
criteria. For instance, methods used for the identification
of differentially expressed genes and over-represented
pathways can be negatively impacted by 1) gene magni-
tude changes, via the fold-change cutoff, 2) the dynamics
of the host responses, as biological condition compari-
sons are usually performed within a given time-point,
and 3) the variability of the biological conditions, via the
p-value cutoff. For example, the comparison of the
VN1203 wild-type condition at 104 PFU and at 2 dpi with
the VN1203-PB1F2del condition at 103 PFU and at 2 dpi
will detect a large number of differentially expressed
transcripts or proteins (Figure 5C). On the other hand, a
comparison of the VN1203 wide-type condition at 104
PFU and at 2 dpi with the VN1203-PB1F2del condition
at 103 PFU and at 2 dpi will detect a smaller number of
differentially expressed transcripts and proteins. How-
ever, in both cases, the virus triggered the same host re-
sponse mechanisms, but with different kinetics.
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Singular Value Decomposition analysis that we used for
the kinetics analysis has several advantages that we
exploited here. This analysis is based on an unsupervised
method and does not require pulling the samples into
distinct groups (i.e. the samples are not grouped by time
points post-infection or by inoculation concentrations).
This unsupervised aspect was crucial in our analysis be-
cause of the shifts on the host response that we described
in this study. Using this SVD analysis strategy, we have
been able to successfully capture the kinetics pattern of
the host response system to VN1203 wild-type without
having to group the samples into particular bins. More-
over, the kinetic patterns of the sub-biological mecha-
nisms identified (eigentranscripts and eigenproteins) can
be naturally displayed with this analysis strategy. These
representations of eigentranscripts and eigenproteins
show in a very concise way the kinetics profiles of all the
associated transcripts and proteins. For example, we have
been able to clearly observe the transient profile of tran-
scripts associated with T-cell responses. With more trad-
itional methods (i.e. gene modules, gene heatmaps or
PCA representations in gene space), this kind of repre-
sentation is not systematic and could produce large unin-
telligible representations.
The MDS Reference Maps and Projections representa-
tions that we developed and used in the context of this
study were particularly useful to drive our analysis. By
using the VN1203 wild-type virus -omics profiles as a
reference representation, we have been able to observe
the behavior of the host response to the other variants.
Traditional visualization representation methods do not
naturally allow fixed positions of a subset of high-
dimensional objects. In the context of the development of
novel visualization methods [40-42], we showed the rele-
vance of this approach for the analysis of large datasets.
Conclusions
The emergent properties of a biological system are dy-
namic and best comprehended by examining the system
through the sum of its individual components [43].
Through a systems biology approach, we have demon-
strated the importance of the kinetics of the host re-
sponse to H5N1 pathogenesis. Magnitude and velocity
represent emergent properties of the system that are
best captured using an expanded time-course, multiple
doses and more than one mutant virus. Therefore,
changes in gene expression induced by wild-type and
mutant virus are not necessarily specific to a particular
mutation, but rather encompass kinetic changes where
increasing viral dosage is found to proportionally in-
crease the Magnitude Coefficient and impact the timing
of peak Velocity Coefficient during infection. Know-
ledge of the timing of host response changes will haveimportant implications for treatment administration,
particularly early in infection.
Methods
Viruses
All recombinant influenza viruses – including H1N1 CA04
wild-type, the H5N1 VN1203 wild-type and the panel of
four H5N1 VN1203 mutant viruses encoding changes in
specific pathogenicity markers – were generated by using
reverse genetics coupled with site-directed mutagenesis
(for mutant viruses), essentially as described previously
[18,44,45].The H5N1 VN1203 mutant viruses included the
following: a virus in which the hemagglutinin (HA) surface
protein poly-basic cleavage site (RERRRKKR↓G) was mu-
tated to (RETR↓G) (referred to as H5N1 VN1203-HAavir
mutant), which has been previously described [2]; a
virus possessing a K→E amino acid substitution at
residue 627 of the PB2 protein (referred to as H5N1
VN1203-PB2627E), which was previously described [4]; a
newly generated virus in which a stop codon mutation was
introduced into the NS1 protein open reading frame at
amino acid 124, which was achieved by a T→A nucleotide
substitution at position 400 of the H5N1 VN1203 NS gene
segment (referred to as H5N1 VN1203-NS1trunc); and a
newly generated virus in which the PB1-F2 open reading
frame was eliminated by introduction of three stop codon
mutations (affected nucleotide positions in the H5N1
VN1203 PB1 gene segment: T120C, C153G, G291A; re-
ferred to as H5N1 VN1203-PB1F2del). Mutations in the
PB1-F2 and NS1 open reading frames did not affect the
coding sequences of collinear PB1 and NS2 proteins, re-
spectively. Primer sequences are available upon request.
Infections and sample collection
All experiments using live H5N1 and H1N1 viruses were
performed in an animal enhanced biosafety level 3 (ABSL3
and ABSL3+) containment laboratories at the University
of Wisconsin-Madison and University of North Carolina,
approved for use by the United States (US) Centers for
Disease Control (CDC) and the US Department of Agri-
culture. All animal experiments and procedures were ap-
proved by the University of Wisconsin-Madison School
of Veterinary Medicine Animal Care and Use Committee
and by the University of North Carolina Institutional
Animal Care and Use Committee. Twenty-week-old fe-
male C57BL/6J mice (Jackson Laboratories) were anes-
thetized by isoflurane inhalation or i.p. ketamine/xylazine
injection and mock-infected or infected with 102, 103,
104, 105 or 106 Plaque Forming Units (PFU) of virus, as
indicated in the text, figures and figure legends. Viruses
were diluted in Minimum Essential Medium (MEM)
containing 0.3% BSA, and the same medium without virus
was used for mock infections. Three to five mice from both
mock-infected and infected groups were euthanized at days
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and divided into multiple lobes for virus titration,
RNA extraction or protein extraction. For each wild-
type or mutant virus, infections were performed in in-
dependent experiments, and the same lung lobe was
collected for each analysis method from every mouse.
Importantly, we did not detect any differences in the
amount of virus recovered from any lung lobe, indi-
cating there was no bias in the distribution of viral infec-
tion in the mouse lungs (Additional file 8: Figure S5).
Individual or group mouse body weights were collected
on a daily basis to monitor the disease course, and
mice were humanely euthanized upon reaching the ex-
perimental endpoint (i.e., sample collection or severe
clinical symptoms).
Median Lethal Dose (MLD) analysis
To determine Median Lethal Dose values (MLD) for
VN1203-WT and mutants, we infected 6-week-old
BALB/C mice with serial dilutions of each virus (3 mice
per dilution) and monitored individual mouse body weight
loss and survival over 14 days. All mice were humanely eu-
thanized either when exhibiting severe clinical symptoms,
or at the end of the 14 day observation period. MLD values
were calculated according to the method of Reed and
Muench [46].
Virus titration
Lung tissues were homogenized using a TissueLyser
(Qiagen) or MagnaLyser (Roche) in 1 ml of MEM
containing a penicillin/streptomycin mixture (Life Tech-
nologies), and following centrifugation to remove debris,
virus titrations were performed in Madin-Darby Canine
Kidney (MDCK) cells using standard methods. Virus
titers are represented as the total number of infectious
viruses isolated per lobe.
Viral mRNA and genomic RNA measurements
Quantification of influenza vRNA and mRNA transcripts
was assessed using a strand-specific real-time RT-PCR
method previously described [47]. Briefly, H5N1 cDNAs
complementary to the two types of influenza viral RNA
from the NP genomic segment were synthesized with
tagged primers to add an 18–20 nucleotide tag that was
unrelated to the influenza virus at the 5’ end (vRNAtag;
GGCCGTCATGGTGGCGAAT and mRNAtag; CCAG
ATCGTTCGAGTCGT). To the mixture, 4 μl of the
RNA sample was added with 1.5 μl of 10 μM primer
specific for the NP genomic segment vRNA (5'-GG
CCGTCATGGTGGCGAATAGCAAAAGCAGGGTAG
ATAATCACTC-3') or mRNA (5'-CCAGATCGTTCGAG
TCGTTTTTTTTTTTTTTTTTCTTTAATTGTC-3') and
made up to 13 μl with RNase free water. The mixture
was then incubated at 65°C for 5 min and was cooledto 4°C. The reaction mixture [5 μl of First Strand buffer
(5×, Invitrogen, Carlsbad, CA), 4 μl of 25 mM MgCl2, 2
μl of 0.1 M dithiothreitol and 1 μl of Superscript II RT
(50 U/μl, Invitrogen)] was then added. The RT reaction
was carried out at 42°C for 60 min and was terminated
by heating at 70°C for 5 min. After the RT reaction,
SYBR-Green I real time PCR was then carried out using
diluted cDNA as a template, in which 1 μl of cDNA
was added to the qPCR reaction mixture [10 μl SYBR
GreenERqPCRSuperMix for ABI PRISM (2×), 1.5 μl of
each primer for the H5N1 NP genomic vRNA (10 μM;
5'-GGCCGTCATGGTGGCGAAT-3’ and 5'-GTTCCCCA
CCAGTTTCCATC-3') or mRNA (5'-CCAGATCGTTCG
AGTCGT-3' and 5'-CGAACCCGATCGTGCCTTCC-3'),
3 μl of double-distilled water]. The cycle conditions of
qPCR were 95°C 10 min, followed by 40 cycles of 95°C
15 s and 60°C for 1 min. H1N1 cDNA was created simi-
larly as above with the NP genomic segment vRNAoligo
listed above or mRNA-specific oligo 5’-CCAGATCGTT
CGAGTCGTTTTTTTTTTTTTTTTTCAACTGTCATA
CTC-3’. The genomic vRNA PCR reactions were as-
sembled identically as above for the H5N1 virus, and
mRNA reaction was assembled with the mRNA oligo
tag primer 5’-CCAGATCGTTCGAGTCG-3’ and H1N1-
specific NP mRNA primer 5’-GCTCCCCACCAGTCTCC
ATT-3’. As an endogenous control, RPL10 mRNA level
was measured using primers 5'-TGAAGACATGGTTG
CTGAGAAG-3' and 5'-GAACGATTTGGTAGGGTAT
AGGAG-3'.
RNA isolation and microarray processing
Lung tissues were directly submerged in RNA-Later
stabilization solution (Life Technologies) following dis-
section, placed at 4°C overnight, followed by freezing
at −80°C. Lung tissues were thawed, transferred to 1 ml
TRIzol (Life Technologies) and homogenized using a
TissueLyser or MagnaLyser. RNA was isolated using
QiagenRNeasy Mini columns and the manufacturer’s
recommended protocol (Qiagen Inc., Valencia, CA). Fluo-
rescently labeled probes were generated from each RNA
sample using Agilent one-color Low Input Quick Amp
Labeling Kit (Agilent Technologies). Individual cRNA
samples were hybridized to oligonucleotide microarrays
for gene expression profiling using Whole Mouse Genome
Microarray Kit (Agilent Technologies). All the microarray
experiments passed the quality control criteria of the
Agilent Feature Extraction Software.
Transcriptomics data extraction and normalization
Transcriptomics data have been extracted from the
AgilentWhole Mouse Genome Microarray raw data
and scale normalized [48-50] using the ‘normalize
BetweenArrays’ normalization method available in ‘limma’
package [51] of the R suite [52].
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All chemicals and reagents were purchased from Sigma-
Aldrich (St. Louis, MO) unless stated otherwise. Am-
monium bicarbonate and acetonitrile were purchased
from Fisher Scientific (Pittsburgh, PA), and sequencing-
grade modified trypsin was purchased from Promega
(Madison, WI). Bicinchoninic acid (BCA) assay reagents
and standards were obtained from Pierce (Rockford, IL);
and purified, deionized water, >18 MΩ, (Nanopure Infinity
ultrapure water system, Barnstead, Dubuque, IA) was used
to make all aqueous buffers. Dissected lung tissues were
directly frozen at −80°C. To prepare protein extracts,
thawed tissues were suspended in 1 ml of 8 M urea in
50 mM NH4HCO3 and homogenized using a TissueLyser
or Magnalyser. Protein concentrations of the cleared ho-
mogenates were determined by BCA protein assay and
diluted to uniform volume in 50 mM ammonium bicar-
bonate, pH 7.8. Proteins were reduced with 10 mM
dithiothreitol, followed by alkylation of free sulfhydryl
groups with 40 mM iodoacetamide at 37°C in the dark;
each reaction was performed for 1 h at 37°C with constant
shaking at 550 rpm. Denatured and reduced samples were
diluted 10-fold with 50 mM ammonium bicarbonate, pH
7.8, and CaCl2 was added to a final concentration of 1 mM
prior to enzymatic digestion. Sequencing-grade modified
trypsin was activated by adding 20 μL of 50 mM ammo-
nium bicarbonate, pH 7.8, to 20 μg lyophilized trypsin and
incubating for 10 min at 37°C. Activated trypsin was then
added to the samples at 1:50 (w/w) trypsin-to-protein ratio,
and samples were digested at 37°C for 3 h with constant
shaking at 800 rpm; reactions were quenched by rapid
freezing in liquid nitrogen. Digested samples were desalted
using solid phase extraction columns (Discovery C18,
Supelco, Bellefonte, PA), according to the manufacturer’s
instructions. Samples were concentrated to 100 μLin vacuo
(Speed-Vac SC 250 Express, Thermo Savant, Holbrook,
NY), and a BCA protein assay was performed to ver-
ify final peptide concentrations. Samples were stored
at −80°C until strong cation exchange fractionation
with liquid chromatography-tandem mass spectrometry
(LC-MS/MS) or quantitative LC-MS analyses.
Strong cation exchange fractionation
Strong cation exchange fractionation was performed as
previously described [53]. Twenty four fractions were
collected from minute 30 to minute 65 of the gradient,
and they were subsequently dried in vacuo and stored
at −80°C until LC-MS/MS analysis.
Reversed-phase capillary LC-MS/MS and LC-MS analyses
Capillary LC-MS/MS analysis was used to generate a
peptide accurate mass and time (AMT) tag database
[54] for virus-infected lung homogenates (see below).
For this, dried peptide fractions were reconstituted in30 μL of 25 mM ammonium bicarbonate, pH 7.8, and ana-
lyzed using a 4-column custom-built capillary LC system
coupled online to a linear ion trap mass spectrometer
(LTQ; Thermo Scientific, San Jose, CA) by way of an in-
house manufactured nanoelectrospray ionization interface,
as previously described [55]. To identify the eluting pep-
tides, the LTQ stage was operated in a data-dependent
MS/MS mode as previously described [53].
Following lung and virus peptide/protein AMT tag
database generation, capillary LC-MS analyses were
performed on all individual H5N1 and mock-infected
samples to generate quantitative data. For this, dried pep-
tide samples were reconstituted in 30 μL of 25 mM
ammonium bicarbonate, pH 7.8, and analyzed in du-
plicate and random order using identical chromato-
graphic and electrospray conditions as for capillary
LC-MS/MS analyses. The LC system was interfaced to an
ExactiveOrbitrap mass spectrometer (Thermo Scientific),
and the temperature of the heated capillary and the ESI
voltage were 250°C and 2.2 kV, respectively. Data were col-
lected over a range of 400–2,000 m/z.
Development of the AMT tag database for virus-infected
C57BL/6J mice
An AMT tag database of identified peptides was devel-
oped for virus-infected lungs, using mock-infected and
virus-infected samples from two studies: 1) H5N1 data
reported here and 2) another with SARS-CoV MA15.
The details of study 2 will be described elsewhere. To
generate the AMT tag database, aliquots of the H5N1-
or mock-infected samples were combined to make the
following pools: 1) mock-infection (all time points), 2)
early infection (1 and 2 d), and 3) late infection (4 and 7 d).
Samples from the SARS-CoV MA15 studies were simi-
larly pooled. Each pool was subjected to strong cation
exchange fractionation as described above, and each
fraction was analyzed by nanocapillary LC-MS/MS.
The SEQUEST analysis software [56] was used to match
the MS/MS fragmentation spectra with sequences from
the April 20, 2010 UniProt/Swiss-Prot rodent protein data-
base, containing 16,244 entries (protein TITIN_Mouse was
removed due to excessive length). The data were also
matched to sequences from the H5N1 viral proteome.
When searching, SEQUEST used a dynamic mass modifi-
cation on methionine residues corresponding to oxidation
(15.99 Da) and a static mass modification on cysteinyl
residues to account for alkylation by iodoacetamide
(57.02 Da). Peptides passing the following filter criteria
were stored as AMT tags in a Microsoft SQL Server data-
base: 1) SEQUEST DelCn2 value (normalized Xcorr differ-
ence between the top scoring peptide and the second
highest scoring peptide in each MS/MS spectrum) ≥ 0.10
and 2) SEQUEST correlation score (Xcorr) ≥ 1.6, 2.4, and
3.2 for fully tryptic peptides with 1+, 2+, and 3+ charge
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tryptic or non-tryptic protein terminal peptides with 2+,
and 3+ charge states, respectively. Fully non-tryptic pep-
tides were excluded, and a minimum peptide length of
6 amino acid residues was required. These criteria
resulted in 39,744 peptides identified with an estimated
false discovery rate of <2% based on a target-decoy data-
base search [57]. The elution times for these peptides
were normalized to a range of 0 to 1 using a predictive
peptide LC normalized elution time (NET) model and
linear regression, as previously reported [58]. A NET
average and standard deviation were assigned to each
identified peptide if the same peptide was observed in
multiple analyses. Both calculated monoisotopic masses
and observed NETs of identified peptides were included
in the AMT tag database. Identified MS/MS spectra
corresponding to peptides in the AMT tag database
are available at the PRoteomicsIDEntification (PRIDE)
database (http://www.ebi.ac.uk/pride/) under the pro-
ject name A Systems Biology Approach to Emerging
Respiratory Viral Diseases in the PRIDE Public Projects
folder and corresponding to PRIDE Accession numbers
19855–19860.
Processing of quantitative LC-MS datasets
Quantitative LC-MS datasets were processed using the
PRISM Data Analysis system [59], which is a series of
software tools developed in-house (e.g. Decon2LS [60]
and VIPER [61]; freely available at http://ncrr.pnl.gov/
software/). Individual steps in this data processing ap-
proach are reviewed here [54]. The peptide identities for
detected features in each dataset (i.e. a single LC-MS
analysis) were determined for features matched to AMT
tags with high confidence based upon the accurate mea-
sured monoisotopic masses and NETs for each of the
39,744 peptides in the filtered AMT tag database within
initial search tolerances of ± 6 ppm and ± 0.025 NET for
monoisotopic mass and elution time, respectively. The
peptides identified from this matching process were
retained as a matrix for subsequent data analysis. The raw
quantitative proteomics data can be accessed at the PNNL
Biological MS Data and Software Distribution Center
(http://omics.pnl.gov/) in the Systems Virology Contract
Data folder within the Browse Available Data folder.
Proteomics data processing, missing values imputation,
and normalization
Quality control processing was performed to identify and
remove contaminant proteins, redundant peptides, pep-
tides with an insufficient amount of data across the set of
samples [62], and LC-MS datasets that showed signifi-
cant deviation from the standard behavior of all LC-MS
analyses [63]. The peptide abundance values were normal-
ized across the technical replicates using a global mediancentering of the data. [64]. The normalized log10
abundance values were averaged across the technical repli-
cates within each biological sample. Peptide level signifi-
cance patterns were used for protein roll-up to select
appropriate peptides for protein quantification. Proteins
were quantified using a standard R-Rollup method using
the most abundant reference peptide [65], after filtering
the peptides that were redundant, had low data content, or
were outside the dominant significance pattern.
Missing expression values into each proteomics profile
have been inferred using the ‘impute.knn’ k-nearest neigh-
bor imputation method [66] available in the ‘imputation’
package [67] of the R suite [52]. In order to avoid inconsist-
ent missing value imputations, the nearest neighbors have
been restricted to proteomics profiles belonging to the
same biological condition. The number of nearest neigh-
bors used in the imputation (the k parameter) has been set
to 2/3 of the number of samples of the biological condi-
tion. Out of the 1,069,500 (3,875x276) proteomic expres-
sion values, 450,814 (42.15%) had to be inferred. Biological
conditions at the earliest time points post-infection showed
the highest degree of imputation, while the biological con-
ditions at the latest time points post-infection showed the
lowest degree of imputation. When expression values for a
protein having been found as missing in more than
2/3 of the number of samples of the biological condition,
the expressions values have been set to 10E-4 in order to
avoid infinite fold-changes values when comparing to
other conditions.
The whole compendium of proteomics expression pro-
files center based on the value of the 9th decile and scale
normalized [48-50] using the ‘normalizeBetweenArrays’
normalization method available in ‘limma’ package [51] of
the R suite [52].
Identification of differentially expressed transcripts
and proteins
Statistically significant differentially expressed transcripts
and proteins have been identified using the CDS method
[68]. The CDS statistical test allows the identification of
differentially but also similarly expressed transcripts and
proteins between two biological conditions using a stat-
istical hypothesis test that formulates fold-change state-
ments. We used a fold-change parameter of 2 for the
identification of differentially expressed transcripts and a
fold-change parameter of 1.2 for the identification of dif-
ferentially expressed proteins. Transcripts or proteins
having a p-value generated by this statistical test lower
than 0.01 have been asset as differentially expressed.
Identification of over-represented biological functions,
canonical pathways and upstream regulators
Functional enrichment of biological functions, canonical
pathways and upstream regulators was performed using
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IPA examines differentially expressed transcripts and
proteins in the context of known biological functions,
mapping each gene identifier to its corresponding mol-
ecule in the Ingenuity Pathways Knowledge Base (IPKB).
For all analyses, the p-values were generated using the
right-tailed Fisher's Exact Test [69].
Upstream Regulator Analysis in IPA incorporates down-
stream target genes from the experimental dataset and
compiled knowledge of reported relationships between reg-
ulators and their known target genes within IPKB. This
analytical tool was used to predict the upstream regulators
in our analysis.
Multidimensional scaling representations
Multidimensional Scaling representations have been gener-
ated using the SVD-MDS method [29]. Multidimensional
scaling methods represent the similarities and differences
amongst high dimensionality objects into a space having a
low number of dimensions, usually in 2 or 3 dimensions
for visualization purposes [28]. Pairwise distances between
the dots are proportional to the transcriptomic or prote-
omic distances between the samples. The Kruskal Stress
criterion [28] shown in the representations, quantifies the
quality of the representations as a fraction of the informa-
tion lost during the dimensionality reduction procedure.
The SVD-MDS method performs the dimensional reduc-
tion procedure by using a molecular dynamics approach
and by initialing the metric space using a singular value
decomposition method, resulting in better representa-
tion of the similarities and differences in term of infor-
mation conservation.
Identification of transcripts and proteins correlating with
the kinetics pattern of the host response to VN1203
wild-type
Transcriptomic and proteomic intensity expression matri-
ces of the wild-type VN1203 infected samples have been
factorized using a Singular Value Decomposition method.
Transcripts and proteins that correlated with at least one
eigentranscript or eigenprotein (right-singular vectors)
were then identified using the Pearson’s coefficient of cor-
relation. We used a cutoff of 0.65 on the Pearson’s coeffi-
cient of correlation and a cutoff of 0.01 on the p-value
associated with this correlation coefficient. The p-values
associated with Pearson’s coefficients of correlation have
been obtained using the Student's t distribution for a trans-
formation of the correlation. Mock infected biological con-
ditions were not used in the inference of eigentranscripts
and eigenproteins, and biological conditions at 1 dpi and 2
dpi were not used in the inference of the eigenproteins be-
cause of the relatively low levels of proteins identified as
differentially expressed at these time-points. In order to
discard transcripts or proteins that could contribute tonoise the analysis, only the transcripts and proteins found
as differentially expressed in at least one biological condi-
tion have been used in the SVD analysis.
The SVD analysis has been performed as described
here after. Both the transcriptomic and proteomic ex-
pression matrices M (m×n, for m genes and n samples)
have been factorized in the form of:
M=USVt where U is a real unitary matrix (m×m), S is a
rectangular diagonal matrix (m×n) with nonnegative
real numbers on the diagonal, and Vt (the conjugate
transpose of V) is a real unitary matrix (n×n).
These factorizations have been done using the “svd”
function of the R suite [52].
The V matrices have been transposed in order to obtain
the eigenvectors (eigentranscripts or eigenproteins). As
52 transcriptomic samples have been used in the SVD
factorization, then 52 eigentranscripts have been identi-
fied. Respectively, as 22 proteomic samples have been
used in the SVD factorization, then 22 eigenproteins have
been identified.
Using an iterative procedure, each vector of tran-
script or protein expression values (of the original
expression matrices) have been compared to the identified
eigentranscripts or eigenproteins. The statistical compari-
son has been done using the Pearson’s coefficient of correl-
ation as described before.
We identified a total of 3 eigentranscripts for which at
least 5 transcripts were correlating, and we identified
a total of 3 eigenproteins for which at least 5 proteins
were correlating.
Magnitude and velocity coefficients
The Magnitude Coefficient (MC) quantifies the magnitude
effect as the transcriptomic distance from one biological
condition to the matched mock-infected condition. The
Velocity Coefficient (VC) quantifies the velocity effect as
the speed of the transcriptomic host response to move
from one time point to the next one. Both the MC and VC
were calculated based on the centroids (arithmetic means)
of the biological conditions and the transcriptomic dis-
tances (Euclidian distances) are calculated based on the
lists of transcripts associated with the kinetics of the host
response to VN1203 wild-type. Namely the MC and VC of
a biological condition bct being the mean vector of gene
expression levels amongst the biological replicates at the
time point t are defined as:
MC bctð Þ ¼ dist mock; bctð Þ and VC bctð Þ ¼ dist bct ; bctþ1ð Þ
Δt
With: dist c1; c2ð Þ ¼ 1n
Xn
i
c1i−c2ið Þ2
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sion levels amongst the matched mock-infected sam-
ples, Δt is the amount of time between t and t+1 in
days, and n is the length of the mean vectors of gene
expression.Multidimensional scaling reference maps and projections
Multidimensional Scaling Reference Maps (MDS Ref
Maps) and projections (MDS Projections) have been
obtained using a modified version of the SVD-MDS
method that we developed and used for this study.
While the original SVD-MDS method presented in [29]
projects a set of high dimensionality objects into a 2 or
3 dimensional metric space, the modified SVD-MDS
method allows to project additional objects over a pre-
defined MDS representation. The predefined MDS rep-
resentation is named MDS Reference Map, and the
overlaid MDS representations are named MDS Projec-
tions. The original SVD-MDS method performs the di-
mensional reduction of the objects by using a molecular
dynamics approach, modeling objects by particles and
pairwise distances between them by repulsion and at-
traction forces. The modified SVD-MDS method assigns
an infinite mass to each object (i.e. particle) of the MDS
Reference Map, resulting in a projection of the add-
itional objects over the predefined representation. The
Kruskal Stress criterion [28] shown in the representa-
tions quantifies the quality of the representations as a
fraction of the information lost during the dimensional-
ity reduction procedure.Availability of supporting data
Mice initial body weight loss, viral titer, viral RNA
and viral mRNA measurements of the datasets used
in this study are available on the Systems Virology web-
site (http://www.systemsvirology.org) on the ‘PROJECT
FOLDERS > Home > Data & Resources > Experimental
Metadata’. The whole compendium of phenotypical
variables measurements used in this study is available
under the accession ‘ST003’.
Proteomics processed data are available on the System
Virology website (http://www.systemsvirology.org) on the
‘PROJECT FOLDERS > Home > Data & Resources >
Proteomic DataPortal’. The normalized expression matrix
of the whole compendium of proteomics profiles used in
this study is available through the accession id ST003.
Transcriptomic raw data used in this study are
available via the following accession identifiers: GSE37569
for the H1N1 CA04 wild-type virus, GSE33263 for
the H5N1 VN1203 wild-type virus, GSE37572 for the
H5N1 VN1203-HAavir mutant, GSE43301 for the
H5N1 VN1203-PB2627E mutant, GSE44445 for the H5N1
VN1203-NS1trunc mutant, GSE43302 for the H5N1VN1203-PB1F2del mutant at 10E-3 PFU, and GSE44441
for the H5N1 VN1203-PB1F2del mutant at 10E-4 PFU.Additional files
Additional file 1: Figure S1. Representation of the collected
transcriptomic and proteomic profiles of infected mouse lungs along the
timeframe. We collected 230 transcriptomic and 198 proteomic profiles
of C57BL/6 mouse lung infected by two wild-type (WT) influenza viruses –
the H1N1 CA04-WT and the H5N1 VN1203-WT viruses – and 4 mutants of
the H5N1 VN1203-WT virus – the H5N1 VN1203-HAavir, H5N1 VN1203-
PB2627E, H5N1 VN1203-NS1trunc, and H5N1 VN1203-PB1F2del – at different
dosage concentrations (102, 103, 104, 105, and 106 Plaque-Forming Unit –
PFU). The transcriptomic and proteomic profiles have been obtained at
different days post-infection (1, 2, 4, and 7 days post-infection – dpi). Each
dot in the representation represents a transcriptomic profile and each square
represents a proteomic profile of a mouse lung sample along the time frame
for the different viruses and infection concentrations. Samples of this dataset
are gathered into 51 transcriptomic biological conditions and 42 proteomic
biological conditions (i.e. set of biological replicates infected by the same
virus, at the same infection concentration, and from the same time point
post-infection), 13 transcriptomic and 11 proteomic dosage conditions
(i.e. set of biological replicates infected by the same virus, and at the same
infection concentration), and 6 strain conditions (i.e. set of biological replicate
infected by the same virus). Time-matched mock-infected transcriptomic and
proteomic profiles have also been collected leading to a total number of 300
transcriptomic and 266 proteomic profiles in our dataset.
Additional file 2: Figure S2. Statistical comparison of titer, mRNA and
genomic RNA. Graphical table showing the statistical comparisons of viral
titer, viral mRNA and viral genomic RNA measurements between all the
infection conditions and at all the time points post-infection. The
Student's t-test has been used to asset the statistical differences between
the groups for all the different kind of measurements. Comparisons
having a p-value less than 0.05 have been colored in red.
Additional file 3: Table S1. List of transcripts correlating with at least
one eigentranscript. For each transcript correlating with at least one
eigentranscript identified in the kinetics of host response to H5N1 VN1203
wild-type, the probe identifier, the associated gene name, the associated
eigentranscript, and the Pearson’s coefficient of correlation are indicated.
Additional file 4: Table S2. List of proteins correlating with at least one
eigenproteins. For each protein correlating with at least one eigenprotein
identified in the kinetics of host response to H5N1 VN1203 wild-type, the
UniProt/SwissProt accession, the associated gene name, the associated
eigenprotein, and the Pearson’s coefficient of correlation are indicated.
Additional file 5: Table S3. Magnitude and Velocity Coefficients and
the phenotypical variables for each transcriptomic biological condition.
For each transcriptomic biological condition, the Magnitude Coefficient
(MC) – quantifying the Euclidian distance to the matched mock-infected
condition – and the Velocity Coefficient (VC) – quantifying the speed of
the host response to move to the next time point – are indicated as well
as the mean of mice body weight loss (mean body weight) and the
difference of the means of viral titer (Δ mean viral titer), viral mRNA
(Δ mean viral mRNA), and mean viral genomic RNA (Δ mean viral gRNA)
between two consecutive time-points.
Additional file 6: Figure S3. Heatmap and over-represented pathways
of the host response to VN1203-WT and VN1203-NS1trunc at 1 dpi.
(A) Heatmap of the transcript expression signals for the VN1203-WT and
VN1203-NS1trunc infected transcriptomic profiles at 1 day-post-infection
and for the 104 PFU inoculation dosage. Values are shown as log2 ratioed
to the mocks infected samples. The dendrogramm representing
transcripts clustering has been constructed using the Euclidian metric
and complete-link clustering method. (B) Functional enrichment on the
800 transcripts found as over-regulated in VN1203-NS1trunc. 104
significantly over-represented pathways have been identified (p-value
cutoff of 0.05) and the top 45 is indicated. For each top over-represented
canonical pathway the p-value (shown as -log10) is indicated.
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http://www.biomedcentral.com/1752-0509/7/69Additional file 7: Figure S4. MDS Projection of transcriptomic profiles
of the CA04 wild-type infected samples over the VN1203 wild-type MDS
Reference Map. (A) Multidimensional Scaling Projection (MDS Projection)
of the transcriptomic profiles of the 103 PFU, 104 PFU, 105 PFU and 106
PFU H1N1 CA04 wild-type dosage conditions over the H5N1 VN1203
wild-type Multidimensional Scaling Reference Map (MDS Reference Map).
Each dot in the representations is the transcriptomic profile of a
biological sample plotted in the intensity space of gene expression.
Pairwise distances between the dots are proportional to the
transcriptomic distances between the samples. MDS Projections allow to
project –omics profiles over a predefined Multidimensional Scaling (MDS)
representation. Euclidian distances have been calculated based on the
signature of transcripts that significantly correlate with one
eigentranscript. Dots are colored in order to indicate the dosage
conditions, and biological conditions are indicated by the convex hull of
the set of biological replicates (i.e. the smallest convex set containing the
points [30]) and labeled to indicate the time point post-infection. Samples
and biological conditions of the H5N1 VN1203 wild-type 104 PFU infection
dosage are indicated by gray dots and gray convex hulls. Hence the grey
spots that are connected represent the transcriptomic profiles of mice
lung infected by the VN1203 wild-type virus at 104 PFU, while the ones
not connected represent the transcriptomic profiles for the other infection
concentrations. The Kruskal Stress shown in each representation quantifies
the quality of the geometrical representation as a fraction of the
information lost during the dimensionality reduction procedure.
Additional file 8: Figure S5. Lung homogeneity. (A) Schematic
representation of a lung with the different lobes used for the experiments
and measurements. (B) Barplot representation of the viral titer measurements
showing that there is no difference in the different lung lobes.
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